Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rozanne Lee

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Biomolecular Screening|March 4, 2008
A high-throughput hybridoma selection method using fluorometric microvolume assay technologyRozanne Lee, Mylinh Tran, Mark Nocerini, et al.
Bioanalysis|May 9, 2014
Interference in immunoassays to support therapeutic antibody development in preclinical and clinical studiesMartin Schwickart, Inna Vainshtein, Rozanne Lee, et al.
Bioanalysis|March 23, 2011
PK-PD modeling of protein drugs: implications in assay developmentLorin K Roskos, Amy Schneider, Inna Vainshtein, et al.
Journal of Pharmaceutical Sciences|October 24, 2012
Pharmacokinetic and pharmacodynamic comparability study of moxetumomab pasudotox, an immunotoxin targeting CD22, in cynomolgus monkeysBing Wang, Meina Liang, Zhenling Yao, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 19, 2016
Development of a new ARCHITECT automated periostin immunoassayNicolette M Jeanblanc, Philip M Hemken, Maria J Datwyler, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Biomolecular Screening|March 4, 2008
A high-throughput hybridoma selection method using fluorometric microvolume assay technologyRozanne Lee, Mylinh Tran, Mark Nocerini, et al.
Bioanalysis|May 9, 2014
Interference in immunoassays to support therapeutic antibody development in preclinical and clinical studiesMartin Schwickart, Inna Vainshtein, Rozanne Lee, et al.
Bioanalysis|March 23, 2011
PK-PD modeling of protein drugs: implications in assay developmentLorin K Roskos, Amy Schneider, Inna Vainshtein, et al.
Journal of Pharmaceutical Sciences|October 24, 2012
Pharmacokinetic and pharmacodynamic comparability study of moxetumomab pasudotox, an immunotoxin targeting CD22, in cynomolgus monkeysBing Wang, Meina Liang, Zhenling Yao, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 19, 2016
Development of a new ARCHITECT automated periostin immunoassayNicolette M Jeanblanc, Philip M Hemken, Maria J Datwyler, et al.
Pageof 1